People

Our Team

OrphAI Therapeutics boasts a highly accomplished team with executional expertise across all stages of clinical development.

Leadership
Brigette Roberts, M.D.
Chief Executive Officer, Director
Paul Boni
Chief Financial Officer
Keith Fandrick, Ph.D.
Chief Operating Officer
Esther Nkrumah, Ph.D.
VP, Clinical Operations
Joan Edwards
Chief Quality Assurance Officer
Brad Parry, Ph.D.
SVP Research and Computational Biology
Senior Medical Advisors
Eric Rowinsky, MD
Kay Tetzlaff, MD
Board of Directors
David Scheer
Jay Fine, Ph.D.
Jonathan Rothberg, Ph.D.
George Rehm
Murat Gunel, M.D.
Vikram Khanna
Brigette Roberts, M.D.
Management
Scott B Kozak
Chief Business Development Officer
Scientific Advisory Board
Lawrence Melvin, Ph.D.
Tian Xu, Ph.D.